35% Of This Encompass Health Insider's Holdings Were Sold
35% Of This Encompass Health Insider's Holdings Were Sold
Viewing insider transactions for Encompass Health Corporation's (NYSE:EHC ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders in relation to shares purchased.
查看過去一年內 Encompass Health 公司(NYSE:EHC)的內部交易,我們發現內部人員淨賣出。這意味着與購買股份相比,內部人員賣出了更多的股份。
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
雖然在長期投資方面內部交易並非最重要的事情,但完全忽略內部交易是愚蠢的。
Encompass Health Insider Transactions Over The Last Year
在過去的一年中,Encompass Health 公司的內部交易
In the last twelve months, the biggest single sale by an insider was when the Chief Medical Officer, Elissa Charbonneau, sold US$850k worth of shares at a price of US$85.02 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$98.91. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. It is worth noting that this sale was only 35% of Elissa Charbonneau's holding. The only individual insider seller over the last year was Elissa Charbonneau.
在過去十二個月裏,最大的一次內部人員賣出是首席醫療官 Elissa Charbonneau 以每股 85.02 美元的價格賣出價值 85萬美元的股份。因此,很明顯一位內部人員想要提前套現,甚至低於當前價格 98.91 美元。當一位內部人員以低於當前價格賣出時,這意味着他們認爲較低的價格是公平的。這讓我們想知道他們對(較高的)最近的估值持何看法。雖然內部人員的賣出並不是一個積極信號,但我們不能確定這是否意味着內部人員認爲股份被充分定價,因此這只是一個微弱的信號。值得注意的是這筆交易僅佔 Elissa Charbonneau 持股的35%。去年唯一一個賣出的個人內部人員是 Elissa Charbonneau。
The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
下面的圖表顯示了公司和個人過去一年的內部交易。如果單擊圖表,您可以查看所有單獨的交易,包括股價、個人和日期!
I will like Encompass Health better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
如果我看到一些大規模內部買入交易,我會更喜歡 encompass health。在我們等待時,請查看這份免費的低估和小盤股票清單,其中包括近期重要的內部買入交易。
Does Encompass Health Boast High Insider Ownership?
encompass health是否擁有高比例內部持股?
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that Encompass Health insiders own 1.3% of the company, worth about US$128m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
我喜歡查看公司內部人員持有的股份數量,以幫助形成我對他們與內部人員是否一致看法的觀點。如果內部人員持有公司的相當數量股份,這是一個很好的跡象。很高興看到 encompass health的內部人員擁有公司1.3%的股份,價值約12800萬美元。我喜歡看到這種程度的內部持股,因爲這增加了管理層考慮股東最大利益的機會。
So What Does This Data Suggest About Encompass Health Insiders?
那這些數據對 encompass health內部人員有何啓示?
There haven't been any insider transactions in the last three months -- that doesn't mean much. While we feel good about high insider ownership of Encompass Health, we can't say the same about the selling of shares. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 1 warning sign for Encompass Health and we suggest you have a look.
過去三個月內沒有任何內部交易,這並不意味着什麼。儘管我們對encompass health高比例內部持股持有樂觀態度,但我們不能說同樣的事情發生在股票的賣出上。因此,這些內部交易可以幫助我們建立關於該股票的觀點,但了解該公司面臨的風險也是值得的。您很可能會感興趣,我們爲encompass health發現了1個警示跡象,並建議您一探究竟。
Of course Encompass Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,包含醫療可能不是最佳的股票買入選擇。因此,您可能希望查看這些優質公司的免費合集。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
譯文內容由第三人軟體翻譯。